These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 14054649)

  • 21. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. XIII. EVALUATION OF 4 TYPHOID VACCINES BY MEANS OF AN ACTIVE MOUSE TEST].
    KUDELSKI Z; MEISLOWA P; RABCZYNSKA F
    Przegl Epidemiol; 1963; 17():89-97. PubMed ID: 14054651
    [No Abstract]   [Full Text] [Related]  

  • 22. Controlled field trials and laboratory studies on the effectiveness of typhoid vaccines in Poland, 1961-64.
    Polish Typhoid Committee
    Bull World Health Organ; 1966; 34(2):211-22. PubMed ID: 5296128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.
    Dumas R; Forrat R; Lang J; Farinelli T; Loutan L
    Adv Ther; 1997; 14(4):160-7. PubMed ID: 10174195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled field trial with dried sorbed paratyphoid B and typhoid vaccines.
    Hejfec LB; Levina LA; Kuz'minova ML; Slavina AM; Levites NE; Abidov AZ; Goncarova LF
    Bull World Health Organ; 1971; 45(6):787-94. PubMed ID: 5004428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. XII. AGGLUTINATING ANTIBODIES IN RABBIT SERA AFTER THE IMMUNIZATION WITH ANTITYPHOID VACCINES].
    MEISLOWA P; RABCZYNSKA F; KUDELSKI Z
    Przegl Epidemiol; 1963; 17():81-7. PubMed ID: 14054902
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of prophylactic vaccination on the epidemiologic status of typhoid fever in Poland 1962-1967].
    Magdzik W
    Przegl Epidemiol; 1969; 23(2):193-203. PubMed ID: 5803032
    [No Abstract]   [Full Text] [Related]  

  • 27. Controlled field trials of paratyphoid B vaccine and evaluation of the effectiveness of a single administration of typhoid vaccine.
    Hejfec LB; Levina LA; Kuz'minova ML; Salmin LV; Slavina AM; Vasil'eva AV
    Bull World Health Organ; 1968; 38(6):907-15. PubMed ID: 4973021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.
    Yang HH; Kilgore PE; Yang LH; Park JK; Pan YF; Kim Y; Lee YJ; Xu ZY; Clemens JD
    J Infect Dis; 2001 Jun; 183(12):1775-80. PubMed ID: 11372030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
    Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
    Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An optimization model for reducing typhoid cases in developing countries without increasing public spending.
    Lauria DT; Maskery B; Poulos C; Whittington D
    Vaccine; 2009 Mar; 27(10):1609-21. PubMed ID: 19146902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The protective effect of typhoid and paratyphoid A and B vaccines. Experiences from several years vaccination trials].
    Onsrud M
    Tidsskr Nor Laegeforen; 1970 May; 90(9):868-72. PubMed ID: 4247444
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vaccination against typhoid/paratyphoid].
    Iwarson S
    Lakartidningen; 1977 Feb; 74(6):409. PubMed ID: 402514
    [No Abstract]   [Full Text] [Related]  

  • 34. Field effectiveness of Vi polysaccharide typhoid vaccine in the People's Republic of China.
    Arya SC
    J Infect Dis; 2002 Mar; 185(6):845; author reply 845-6. PubMed ID: 11920305
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccination against typhoid fever in travellers: a cost-effectiveness approach.
    Papadimitropoulos V; Vergidis PI; Bliziotis I; Falagas ME
    Clin Microbiol Infect; 2004 Aug; 10(8):681-3. PubMed ID: 15301670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Typhoid vaccination: the Asian experience.
    DeRoeck D; Ochiai RL; Yang J; Anh DD; Alag V; Clemens JD
    Expert Rev Vaccines; 2008 Jul; 7(5):547-60. PubMed ID: 18564010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy.
    Bahl R; Sinha A; Poulos C; Whittington D; Sazawal S; Kumar R; Mahalanabis D; Acosta CJ; Clemens JD; Bhan MK
    J Health Popul Nutr; 2004 Sep; 22(3):304-10. PubMed ID: 15609783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
    Beeching NJ; Clarke PD; Kitchin NR; Pirmohamed J; Veitch K; Weber F
    Vaccine; 2004 Nov; 23(1):29-35. PubMed ID: 15519704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Typhim Vi vaccine against typhoid fever: a clinical trial in Kenya.
    Mirza NB; Wamola IA; Estambale BA; Mbithi E; Poillet M
    East Afr Med J; 1995 Mar; 72(3):162-4. PubMed ID: 7796767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.